SynthesisAnti-cancer agents in medicinal chemistry2026

Comparative Prognosis of HER2-Low versus HER2-Negative Breast Cancer: A Meta-Analysis.

Yuanyuan Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.